Systemic capillary leak syndrome (SCLS) is characterized by recurrent hypovolemic shock attributable to increased systemic capillary leakage. A 46-year-old man was admitted to our hospital because of recurrent episodes of generalized edemawith hypovolemicshock. Blood laboratory data revealed severe hypoproteinemia with a small monoclonal IgG-K protein. These findings suggested strongly the diagnosis of SCLS. A regimen with steroid pulse therapy was tried; however, intravascular overloading accompanied by the recruitment of the initially extravasated fluids resulted in acute pulmonaryedema. Intensive care and careful monitoring of fluid volume are required in SCLS. (Internal Medicine 41: 953-956, 2002) 
Introduction
Systemic capillary leak syndrome (SCLS) was first reported by Clarkson and colleagues (1) in 1960. The syndrome is characterized by chronic recurrent episodes of a triad of hypotension, hypoalbuminemia and hemoconcentration associated with paraproteinemia (2) . Rare complications of SCLSare renal damage and rhabdomyolysis, attributable to increased compartment pressure and ischemic myonecrosis (3) . The degree of hemoconcentrationrelates to the overall severity of the acute phase of SCLS.SCLSoften presents with an associated monoclonal gammopathy without any evidence of multiple myeloma or amyloidosis. The IgG class monoclonal gammopathy predominates, with either k or X light chains. Although more than seventy cases have been reported the pathogenesis of this syndrome remains unclear.
Wedescribe a case of SCLS, with recovery from severe hypovolemic shock accompanied by pulmonary edema, and review the literature, with particular regard to the pathophysiology and the treatment of the syndrome.
For editorial comment, see p 909.
Case Report
A 46-year-old manwas admitted to our hospital because of generalized edema and disturbance of consciousness. In March 1999, at the age of 45, the previously healthy man had a sore throat, cough, and fever for several days. Onemonth later, puffiness of the face and leg edema developed and required clinical evaluation elsewhere. His body weight rose from 60 kg to 64 kg. On June 15, 1999, he was admitted to another hospital.
Blood laboratory data revealed hypoproteinemia: total protein 5.6 g/dl, serum albumin 3.6 g/dl. A chest radiograph showed bilateral, slight pleural effusions. Common causes of generalized edema accompanied by hypoproteinemia, such as nephrotic syndrome, liver dysfunction, congestive heart failure and gastrointestinal protein losing enteropathy, were excluded. Twenty mg/day doses of loop diuretics were started and the generalized edema gradually disappeared. On July 10, he was discharged from the hospital. One-week later, generalized edema and general fatigue returned, accompanied by nausea. He complained of excessive sweating and shortness of breath. On July 19, 9 days after discharge, he was brought to our hospital because of generalized edema and disturbance of consciousness (Fig. 1) PaCO2 25.7 mmHg, and HCO3~10.4 mmol/Z. All adrenal hormoneswere beyond the upper levels of the normal ranges. A chest radiograph revealed slight pleural effusion without abnormal shadows in the lungs. An echocardiogram did not show any signs of pericardial effusion. The left ventricular ejection fraction was 81%and wall motion was normal. The patient had a small amount of monoclonal IgG-K protein (6.1 g//) in his serum. Bence-Jones proteinuria was negative. Wediagnosed his illness as hypovolemic shock accompanied by hypoproteinemia. On the 7th hospital day, bone marrowaspiration was carried out and was approximately normal. A total of 10 / of fluid and a 20 g dose of albumin were administered intravenously during the first 72 hours. On days 2 and 3, a 1,000 mg dose of hydrocortisone was administered intravenously. In spite of the disappearance of generalized edema, dyspnea started. A chest radiograph revealed congestion of the lung and blood gas analysis (100% O2 10 Z/min) showed pH 7.344, PaO2 28.7 mmHg, PaCO2 46.0 mmHgand HCO3~24.5 mmol/Z. On the third hospital day, he was intubated and mechanical ventilation was maintained. A twenty gram dose of albumin was administered intravenously for one hour and then 60 mg of furosemide was injected intravenously as a single dose. Because the urine volume was less than 1,000 ml daily and dyspnea worsened, continuous extracorporeal ultra filtration was performed and 80 ml/h of water removed for 48 hours from the third hospital day. Fromthe fourth hospital day, urine output increased gradually and blood gas analysis showed improvement of pulmonary congestion. Mechanical ventilation was discontinued and the dose of furosemide was reduced to 20 mg per day on the 9th hospital day. On the 7th hospital day, plasma cytokines showed the following values: interleukin-2 non-detectable (normal range <0.8), vascular endothelium growth factor (VEGF) 75 pg/ml (62-707 pg/ml), complement-3a (C3a) 4,430 ng/ml (50-200 ng/ml), and complement-5a (C5a) nondetectable (<10). The patient experienced a progressive reduction in his body weight and a resolution of the generalized edema. A chest radiograph showed no pleural effusion. On the 20th hospital day, gastrointestinal examination showed no evidence of gastritis, gastrointestinal ulcer or malignancy. From these data, we diagnosed his illness as SCLS. On the 50th hospital day, plasma cytokines including interleukin-2, VEGF, C3a, and C5a were all within normal levels. Onthe 57th hospital day, his body weight was 59 kg and laboratory findings showed total protein 6.8 g/dl, albumin 4.3 g/dl, blood urea nitrogen 12 mg/dl, and creatinine 0.80 mg/dl and a small monoclonal IgGk (10.0 g//) protein was found in his serum. He was discharged from our hospital.
Discussion
Wedescribed a 46-year-old manwho was hospitalized because of a 3-month history of recurrent generalized edema and hypotension accompanied by hypoproteinemia. The clinical and laboratory findings of our patient suggested strongly the diagnosis of SCLS. The detection of a serum monoclonal antibody, IgG-K paraprotein, also supports the diagnosis of SCLS. During the capillary leakage phase, we infused fluid to maintain perfusion pressure for the kidneys, brain, heart and other vital organs. However, because of this process, an episode of acute pulmonary edema occurred on the 3rd hospital day. He was intubated and support with mechanical ventilation was begun. Continuousextracorporeal ultra filtration wasstarted. From these consequent events, acute pulmonary edema was produced by two mechanisms, the recruitment of the initially extravasated fluids and our supplementation of fluid. SCLSis a rare condition characterized by recurrent episodes of generalized edema and severe hypotension, associated with unexpected episodic capillary high-permeability. Episodic attacks are characterized by a marked shift of plasma, up to 70%, from the intravascular space to the extravascular space. This syndrome presents with a characteristic triad of hypotension, hemoconcentration, and hypoalbumiuria. The average age is 46 years (range, 9 to 69 years) and the male: female ratio is (4) hypothesized that a monoclonalimmunoglobulincould be responsible for endothelial damage and capillary hyperpermeability. Zhang et al (6) reported that paraproteins from patients with SCLSdo not exert any cytotoxic effect, alone or in the presence of neutrophils, towards cultured human endothelial cells. In SCLSpatients, numbersof mononuclearcells expressing the interleukin-2 (IL-2) receptor have been reported to be increased markedly during the capillary leakage phase (7) . Early activation of the classical pathway of complement has been reported in other cases (8) . Interestingly, in our case, C3a was high but serum IL-2 was at a normal level on the 7th hospital day. Onthe 57th hospital day, C3awas within normal limits. Fromthese data, there is a possibility that activation of the complementpathway played some role in the present case. Multiple regimens, based on possible pathological mechanisms, have been tried with various degrees of success, including theophylline, terbutaline, salbutamol, steroids, diuretics, calcium antagonists, plasmapheresis and Gingko biloba extracts (9) . Although morbidity and mortality rates associated with SCLSare high, the prognosis seems to have improved recently (4) . Of the first 25 cases described, 19 (76%) did not survive 5 years after the diagnosis of SCLS. Amoura et al (4) (6) . At the peak of an SCLSepisode, the clinical features include generalized edema, intestinal edema, ascites, pleural and pericardial effusions ( 1 0). In this phase, the cerebral, coronary and renal circulation are decreased because of hypovolemicshock. Rhabdomyolysis may be an important complication of SCLS(3). Acute renal failure can result from acute tubular necrosis because of hypovolemic shock accompanied by rhabdomyolysis (3). The recruitment phase follows the capillary leak phase and involves the normalization of the extraordinary vascular leakage, resulting in recruitment of the initially extravasated fluid and macromolecules. In the recruitment phase, intravascular overload may occur easily and result in acute pulmonary edema. In the present case, acute pulmonary edema developed on the 3rd hospital day and the patient was intubated and mechanical ventilation was performed. Wespeculate that intravascular overloading accompanied by the recruitment of the initially extravasated fluids and macromolecules resulted in acute pulmonary edema.
In the present case, we treated our patient with steroid pulse therapy in the acute capillary leak phase. Steroid administration may have a role during the capillary leak phase, when cytokine-mediated mechanismsof endothelial damageare prominent (10) . It was shown that macromolecule leakage in response to various stimuli, including histamine and bradykinin, can be inhibited by pretreatment with (32 stimulants, terbutaline-selective (32 stimulant and isoprenaline (1 1). The combination of terbutaline and aminophylline therapy has been reported as a first line prophylactic therapy by Droder et al (12) and has been used by several authors (9, 10, 12) . Recently, Tahirkheli et al (10) reported that a regimen of terbutaline and theophylline seemsto be effective prophylaxis against SCLS. Both terbutaline and theophylline are thought to interfere with capillary permeability and to antagonize the effects of cytokines or other mediators, inducing endothelial damageand vascular hyperpermeability. However, no efficacious pharmacological treatment has been clearly established. Wereport a case of a SCLS. Intravascular overloading accompanied by the recruitment of the initially extravasated fluids and macromolecules resulted in acute pulmonary edema. Intensive care unit and careful monitoring of fluid volume are necessary in SCLS.
